1. Home
  2. SOUN vs IDYA Comparison

SOUN vs IDYA Comparison

Compare SOUN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundHound AI Inc

SOUN

SoundHound AI Inc

N/A

Current Price

$7.92

Market Cap

3.1B

Sector

Technology

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$32.70

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOUN
IDYA
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SOUN
IDYA
Price
$7.92
$32.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$16.83
$51.21
AVG Volume (30 Days)
21.7M
789.8K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
$102.14
N/A
Revenue Next Year
$37.14
$97.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$6.52
$13.45
52 Week High
$22.17
$39.28

Technical Indicators

Market Signals
Indicator
SOUN
IDYA
Relative Strength Index (RSI) 37.34 48.38
Support Level $7.04 $29.47
Resistance Level $7.85 $33.03
Average True Range (ATR) 0.59 1.58
MACD 0.03 0.02
Stochastic Oscillator 35.72 63.21

Price Performance

Historical Comparison
SOUN
IDYA

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: